Patents Assigned to Summa Health Systems, LLC
  • USE OF TRANSFORMING GROWTH FACTOR-B RECEPTOR INHIBITORS TO SUPPRESS OCULAR SCARRING
    Publication number: 20100267731
    Abstract: A pharmaceutical composition useful in the prevention of subconjunctival scarring that may occur after GFS comprising an effective amount of an ALK-5 inhibitor. Also disclosed is a method of treating disorder or condition of other ocular scarring or fibrosis including corneal haze and PVR that may develop after ocular surgery or injury comprising applying an amount of a pharmaceutical composition including an ALK-5 inhibitor to a post-surgical or injury site.
    Type: Application
    Filed: April 16, 2010
    Publication date: October 21, 2010
    Applicant: Summa Health Systems, LLC
    Inventor: Hiroshi Nakamura